Armata Pharmaceuticals ARMP Q1 2026 earnings

FAQ

When did Armata Pharmaceuticals report Q1 2026 earnings?

Armata Pharmaceuticals (ARMP) reported Q1 2026 earnings on May 13, 2026 before market open.

What were Armata Pharmaceuticals's Q1 2026 revenue and EPS?

Armata Pharmaceuticals reported revenue of $789.0K and eps of $-3.16 for Q1 2026.

Did Armata Pharmaceuticals beat estimates in Q1 2026?

Revenue beat the consensus estimate of $740.0K by $49.0K. EPS missed the consensus estimate of $-0.38 by $2.78.

How did Armata Pharmaceuticals's Q1 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 60.7% from $491.0K a year earlier and eps declined 1480.0% from $-0.20.

Where can I find Armata Pharmaceuticals's Q1 2026 SEC filings?

You can read the 8-K earnings release (0001104659-26-060299) and the 10-Q periodic report (0001104659-26-060333) directly on SEC EDGAR. The filing index links above go to sec.gov.